Moreover, as T cell proliferation and differentiation are IL-2-dependent processes, the high expression of CD25 on Tregs enables them to outcompete effector T cells for IL-2, resulting in cytokine deprivation that impairs effector T cell responses and contributes to immune suppression within the tumor microenvironment (41). The gene discussed is IL2; the disease is neoplasm.